Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OptimizeRx Corp | 399,320 | reported | 11 Jun 2025 | tx 34+425,830−16,098 |
| BIOVIE INC. | 330,500 | reported | 05 Jan 2026 | tx 21+3,995,756 |
| HALOZYME THERAPEUTICS, INC. | 4,685 | reported | 05 May 2026 | tx 4+12,067 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 3,796 | 0.00 USD | |
| 05 May 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 6,040 | 0.00 USD | deriv |
| 05 Jan 2026 | GRANT_AWARD | BIOVIE INC. | 90,000 | 0.00 USD | deriv |
| 05 Jan 2026 | GRANT_AWARD | BIOVIE INC. | 330,500 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 889 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | HALOZYME THERAPEUTICS, INC. | 1,342 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | OptimizeRx Corp | 9,868 | 0.00 USD | |
| 14 Mar 2025 | PURCHASE | OptimizeRx Corp | 321,408 | 7.60 USD | first after silence |
| 20 Nov 2024 | GRANT_AWARD | BIOVIE INC. | 61,600 | 0.00 USD | deriv |
| 20 Dec 2024 | GRANT_AWARD | BIOVIE INC. | 22,690 | 0.00 USD | deriv |
| 05 Jun 2024 | EXERCISE | OptimizeRx Corp | 10,061 | 0.00 USD | |
| 07 Jun 2024 | GRANT_AWARD | OptimizeRx Corp | 13,286 | 0.00 USD | |
| 05 Jun 2024 | EXERCISE | OptimizeRx Corp | 10,061 | 0.00 USD | deriv |
| 09 Nov 2023 | GRANT_AWARD | BIOVIE INC. | 93,500 | 0.00 USD | deriv |
| 07 Jun 2023 | EXERCISE | OptimizeRx Corp | 4,637 | 0.00 USD | |
| 07 Jun 2023 | GRANT_AWARD | OptimizeRx Corp | 10,061 | 0.00 USD | deriv |
| 07 Jun 2023 | EXERCISE | OptimizeRx Corp | 4,637 | 0.00 USD | deriv |
| 30 Mar 2023 | EXERCISE | OptimizeRx Corp | 657 | 0.00 USD | |
| 30 Mar 2023 | EXERCISE | OptimizeRx Corp | 657 | 0.00 USD | deriv |
| 23 Nov 2022 | GRANT_AWARD | BIOVIE INC. | 43,578 | 0.00 USD | |
| 30 Dec 2022 | EXERCISE | OptimizeRx Corp | 409 | 0.00 USD | |
| 30 Dec 2022 | EXERCISE | OptimizeRx Corp | 409 | 0.00 USD | deriv |
| 29 Sept 2022 | EXERCISE | OptimizeRx Corp | 334 | 0.00 USD | |
| 29 Sept 2022 | EXERCISE | OptimizeRx Corp | 334 | 0.00 USD | deriv |
| 19 Aug 2022 | PURCHASE | OptimizeRx Corp | 6,000 | 16.45 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Mar 2025.